Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

J App Pharm Sci. 2023; 13(11): 101-110


Avicularin: The major secondary metabolite isolated from Saurauia vulcani as a potential anti-colorectal cancer agent

Gunawan Pasaribu, Sumi Hudiyono, Antonius Herry Cahyana, Gustan Pari, Andi Rifki Rosandi, Sofa Fajriah.




Abstract
Cited by 0 Articles

Saurauia vulcani flora develops certainly in North Sumatra Province, Indonesia. It is normally consumed as an antidiabetic remedy and a treatment related to digestion diseases. This research aims to isolate the major compound from S. vulcani plants and assess the bioactivity of the S. vulcani plant for its anti-colorectal cancer potential. Subsequently, the ethyl acetate fraction was analyzed with a solvent system used as the eluent ethyl acetate: methanol: Aquadest = 4.6:0.2:0.2. Utilizing spectroscopy, we determined the chemical structure of the remote substance. Utilizing the 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide technique in vitro, the anti-colorectal cancer activity was demonstrated against WiDr cancer cells. This study revealed that the major compound was identified as avicularin. The avicularin compound is a flavonoid group known to have anticancer activity. The cytotoxicity of avicularin compound was assessed against the WiDr cell line, with a 50% inhibition concentration value of 521.14 μg/ml. The bioactivity of the ethyl acetate fraction is stronger than that of the isolated part (avicularin compound).

Key words: Saurauia vulcani, plant leaves, extract, colorectal cancer, avicularin






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.